FDA Proposes Drug Products, Categories That Would Not Be Eligible for Compounding
- March 22, 2024
The Food and Drug Administration (FDA) published March 20 a proposed rule (89 Fed. Reg. 19776) that would establish criteria for the lists of drug products or categories of drug products that present “demonstrable difficulties for compounding” (DDC Lists) under the Federal Food, Drug, and Cosmetic Act.
ARTICLE TAGS
You must be logged in to access this content.